BioSupply Trends - Marketplace News
FFF Enterprises FFF Enterprises | Home FFF Enterprises | Contact Us
FFF Enterprises | Patient Safety + Product Efficacy + Fair Pricing
 
In This Issue
  • IVIG Supply Index
  • Albumin Supply Index
  • Open Market Pricing
  • Reimbursement Rates
  • Industry News
  • Subscribe to BST Quarterly
  • Subscribe to IG Living
  • MyFluVaccine Orders
  • Resources
Subscribe to BioSupply Trends eNewsletter
 
FFF Enterprises | Free Reference Charts for Hyperimmunes, Immune Globulins, Factor and Injectable Influenza
Hyperimmune
Immune Globulin
Factor
Injectable Influenza
Place Your Flu Vaccine Order on MyFluVaccine.com
Place Your Flu Vaccine Order on MyFluVaccine.com
Subscribe to BioSupply Trends Quarterly magazine
BioSupplyTrends Quarterly magazine, your definitive source for the biopharmaceuticals marketplace
Subscribe to IG Living! magazine
IG Living! magazine, the magazine for the immune globulin community
FFF Enterprises | Helping Healthcare Care - place an order

Flu Is Here!
The Centers for Disease Control and Prevention is reporting that for the last 2 weeks flu activity across the country has picked up, and that about 15 percent of tests at different surveillance sites around the nation are positive for influenza.
Read the full article »

 
 
      
 
IVIG Supply Index represents  FFF's aggregate inventory of  all IVIG products for all our  customers who have established  product allocations with us  (not individual or group  allocations).  Blue represents 21 days supply or less, purple is 22 to 29 days, green is 30 days supply or more.  Albumin Supply Index represents FFF's aggregate inventory of Albumin for all our customers who have  established product allocations  with us (not individual or group  allocations). Blue represents 21 days supply or less, purple is 22 to 29 days, green is 30 days supply or more.
 
FFF Enterprises | Open Market Pricing
 
  
 
Current CMS / IVIG Rates
Rates per gram are effective January 1, 2012 through March 31, 2012.
Product Hospital Outpatient Physician's Office
Carimune NF 60.48 61.64
Flebogamma 5% & 10% DIF 70.15* 70.15
Gammagard Liquid 74.43 75.86
Gammagard S/D 60.48 61.64
Gammaked 73.82 75.24
Gammaplex 74.59* 74.59
Gamunex-C 73.82 75.24
Octagam 111.60† 113.75‡
Privigen 68.81 70.13

*ASP + 6% (pass-through drug)
†WAC + 4% (based on Wholesale Acquisition Cost until ASP is re-established)
‡WAC + 6% (based on Wholesale Acquisition Cost until ASP is re-established)

 
  
 

Industry News

From Science Daily
Big Step Toward Vaccine for Hepatitis C
more »

From CSL Behring
Medical Experts Who Participated in CSL Behring's Key Issues Dialogue Prefer Albumin for Fluid Management
more »

From Medical News Today
Molecular Basis for the Development of New Drugs Against Autoimmune Diseases
more »

From CDC
Novel Swine Influenza Virus Subtype H3N1, United States
more »

From Medical News Today
Key Peptides Identified that Could Lead to a Universal Vaccine for Influenza
more »

 
 
 
   
   
 
FFF Enterprises | Patient Safety + Product Efficacy + Fair Pricing
Home | About Us | Contact   ©2011 FFF Enterprises, Inc.